Cookson Peirce & CO Inc Novo Cure LTD Transaction History

Cookson Peirce & CO Inc

  • $2.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$124.11 - $190.17 $21.6 Million - $33.1 Million
-174,042 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$112.16 - $174.14 $18.6 Million - $29 Million
166,273 Added 2140.21%
174,042 $30.1 Million
Q3 2020

Nov 04, 2020
BUY
$58.05 - $111.31 $450,990 - $864,767
7,769 New
7,769 $864,000

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.03B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email